Found: 42
Select item for more details and to access through your institution.
Diminished amyloid-beta burden in Tg2576 mice following a prophylactic oral immunization with a salmonella-based amyloid-beta derivative vaccine.
- Published in:
- 2009
- By:
- Publication type:
- journal article
The association between anxiety and Alzheimer's disease plasma biomarkers across stages.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.080554
- By:
- Publication type:
- Article
Diagnostic of Novel Plasma Biomarkers in Controls, SCD and MCI Subjects.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.075989
- By:
- Publication type:
- Article
Comparison of serum neurodegenerative biomarkers among hospitalized COVID‐19 patients versus non‐COVID subjects with normal cognition, mild cognitive impairment, or Alzheimer's dementia.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 5, p. 899, doi. 10.1002/alz.12556
- By:
- Publication type:
- Article
Amelioration of tau related pathology with a novel anti‐prion protein monoclonal antibody in an AD mouse model.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.054074
- By:
- Publication type:
- Article
Plasma biomarkers of neurodegeneration and neuroinflammation in hospitalized COVID‐19 patients with and without new neurological symptoms.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.057892
- By:
- Publication type:
- Article
P4‐223: PASSIVE IMMUNIZATION WITH THE NOVEL MONOCLONAL ANTI‐PRP ANTIBODY TW1 IN AN ALZHEIMER'S MOUSE MODEL.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1528, doi. 10.1016/j.jalz.2018.07.044
- By:
- Publication type:
- Article
Anti-β-sheet conformation monoclonal antibody reduces tau and Aβ oligomer pathology in an Alzheimer's disease model.
- Published in:
- Alzheimer's Research & Therapy, 2018, v. 10, p. 1, doi. 10.1186/s13195-018-0337-3
- By:
- Publication type:
- Article
A MONOCLONAL ANTI-OLIGOMER IGM CROSSES THE BBB AND PRODUCES COGNITIVE RESCUE BY LOWERING OLIGOMERIC FORMS OF BOTH TAU AND Aβ IN AN AD ANIMAL MODEL.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P1487, doi. 10.1016/j.jalz.2017.07.568
- By:
- Publication type:
- Article
DISEASE MODIFYING THERAPY BY THE INFUSION OF AN ANTI-CONFORMATIONAL MONOCLONAL ANTIBODY IN AN AB AND TAU 3XTG MOUSE MODEL OF ALZHEIMER’S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P360, doi. 10.1016/j.jalz.2016.06.667
- By:
- Publication type:
- Article
AN AFFIBODY TO MONOMERIC Aβ AS A NOVEL THERAPEUTIC APPROACH FOR ALZHEIMER'S DISEASE PATHOLOGY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P835, doi. 10.1016/j.jalz.2016.06.1708
- By:
- Publication type:
- Article
Aβ immunization in old mouse lemur primates induces cerebral microhemorrhages and accelerates age-associated iron deposits in the choroid plexus
- Published in:
- 2012
- By:
- Publication type:
- Abstract
Targeting hyperphosphorylated tau protein with a monoclonal antibody at an advanced stage of tau pathology improves cognition in a mouse model
- Published in:
- 2011
- By:
- Publication type:
- Abstract
In vivo follow-up of cerebral aging and side effects of anti-amyloid immunotherapies in the mouse lemur primate
- Published in:
- 2011
- By:
- Publication type:
- Abstract
In vivo follow-up of cerebral aging and side effects of anti-amyloid immunotherapies in the mouse lemur primate
- Published in:
- 2011
- By:
- Publication type:
- Abstract
Passive tau immunotherapy diminishes functional decline and clears tau aggregates in a mouse model of tauopathy
- Published in:
- 2010
- By:
- Publication type:
- Abstract
Aß derivative vaccination in old mouse lemur primates
- Published in:
- 2010
- By:
- Publication type:
- Abstract
MRI of Histological Tissue: Effect of Passive Gadolinium-Staining
- Published in:
- 2010
- By:
- Publication type:
- Abstract
Influence of presenilin mutation on tau pathology in a novel Alzheimer's disease mouse model
- Published in:
- 2009
- By:
- Publication type:
- Abstract
Toll-like receptor 9 ligand CpG ODN as a new highly effective agent for prevention and/or treatment of Alzheimer's disease
- Published in:
- 2009
- By:
- Publication type:
- Abstract
Immunotherapy targeting Alzheimer's phospho-tau epitope within the microtubule binding region of tau clears pathological tau and prevents functional decline in a mouse model of tauopathy
- Published in:
- 2009
- By:
- Publication type:
- Abstract
P2-405: Induction of toll-like receptor 9 signaling as a method for preventing or ameliorating Alzheimer's disease
- Published in:
- 2008
- By:
- Publication type:
- Abstract
P1-021: Neuropathological evaluation of the nonhuman primate microcebus murinus immunized with K6Aβ1-30, an Aβ derivative peptide
- Published in:
- 2008
- By:
- Publication type:
- Abstract
O4-04-04: Tau immunotherapy prevents cognitive decline and clears pathological Tau in a tangle mouse model
- Published in:
- 2008
- By:
- Publication type:
- Abstract
O4-01-05: Presenilin 1 mutation promotes Tau phosphorylation and aggregation in a novel Alzheimer's disease mouse model
- Published in:
- 2008
- By:
- Publication type:
- Abstract
P4-316: Aβ derivative vaccine does not cause brain microhemorrhages in Tg2576 mice and its effectiveness is age-dependent
- Published in:
- 2006
- By:
- Publication type:
- Abstract
P4-316: Aβ derivative vaccine does not cause brain microhemorrhages in Tg2576 mice and its effectiveness is age-dependent
- Published in:
- 2006
- By:
- Publication type:
- Abstract
Detection of Amyloid Plaques Targeted by Bifunctional USPIO in Alzheimer’s Disease Transgenic Mice Using Magnetic Resonance Microimaging.
- Published in:
- PLoS ONE, 2013, v. 8, n. 2, p. 1, doi. 10.1371/journal.pone.0057097
- By:
- Publication type:
- Article
Immunotherapeutic approaches for Alzheimer’s disease in transgenic mouse models.
- Published in:
- Brain Structure & Function, 2010, v. 214, n. 2/3, p. 201, doi. 10.1007/s00429-009-0236-2
- By:
- Publication type:
- Article
Induction of Toll-Like Receptor 9 Signaling as a Method for Ameliorating Alzheimer's Disease-Related Pathology.
- Published in:
- Journal of Neuroscience, 2009, v. 29, n. 6, p. 1846, doi. 10.1523/JNEUROSCI.5715-08.2009
- By:
- Publication type:
- Article
Immunotherapy Targeting Pathological Tau Conformers in a Tangle Mouse Model Reduces Brain Pathology with Associated Functional Improvements.
- Published in:
- Journal of Neuroscience, 2007, v. 27, n. 34, p. 9115, doi. 10.1523/JNEUROSCI.2361-07.2007
- By:
- Publication type:
- Article
Affibody-Mediated Sequestration of Amyloid β Demonstrates Preventive Efficacy in a Transgenic Alzheimer's Disease Mouse Model.
- Published in:
- Frontiers in Aging Neuroscience, 2019, p. N.PAG, doi. 10.3389/fnagi.2019.00064
- By:
- Publication type:
- Article
The active form of glycogen synthase kinase-3β is associated with granulovacuolar degeneration in neurons in Alzheimer's disease.
- Published in:
- Acta Neuropathologica, 2002, v. 103, n. 2, p. 91, doi. 10.1007/s004010100435
- By:
- Publication type:
- Article
Blocking the apolipoprotein E/Amyloid β interaction in triple transgenic mice ameliorates Alzheimer's disease related amyloid β and tau pathology.
- Published in:
- Journal of Neurochemistry, 2014, v. 128, n. 4, p. 577, doi. 10.1111/jnc.12484
- By:
- Publication type:
- Article
Passive immunization targeting pathological phospho-tau protein in a mouse model reduces functional decline and clears tau aggregates from the brain.
- Published in:
- Journal of Neurochemistry, 2011, v. 118, n. 4, p. 658, doi. 10.1111/j.1471-4159.2011.07337.x
- By:
- Publication type:
- Article
Passive Immunization With a Novel Monoclonal Anti-PrP Antibody TW1 in an Alzheimer's Mouse Model With Tau Pathology.
- Published in:
- Frontiers in Aging Neuroscience, 2021, p. N.PAG, doi. 10.3389/fnagi.2021.640677
- By:
- Publication type:
- Article
Vaccination of Alzheimer's model mice with Aβ derivative in alum adjuvant reduces Aβ burden without microhemorrhages.
- Published in:
- European Journal of Neuroscience, 2006, v. 24, n. 9, p. 2530, doi. 10.1111/j.1460-9568.2006.05149.x
- By:
- Publication type:
- Article
Tau-based therapeutic approaches for Alzheimer's disease - a mini-review.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Tau-Based Therapeutic Approaches for Alzheimer's Disease - A Mini-Review.
- Published in:
- Gerontology, 2014, v. 60, n. 5, p. 381, doi. 10.1159/000358875
- By:
- Publication type:
- Article
The Innate Immune System in Alzheimer's Disease.
- Published in:
- International Journal of Cell Biology, 2013, p. 1, doi. 10.1155/2013/576383
- By:
- Publication type:
- Article
Immunotherapy Targeting Pathological Tau Prevents Cognitive Decline in a New Tangle Mouse Model.
- Published in:
- Journal of Neuroscience, 2010, v. 30, n. 49, p. 16559, doi. 10.1523/JNEUROSCI.4363-10.2010
- By:
- Publication type:
- Article
Immunotherapy Targeting Pathological Tau Prevents Cognitive Decline in a New Tangle Mouse Model.
- Published in:
- Journal of Neuroscience, 2010, v. 30, n. 48, p. 16559, doi. 10.1523/JNEUROSCI.4363-10.2010
- By:
- Publication type:
- Article